ATE233104T1 - Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika - Google Patents

Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika

Info

Publication number
ATE233104T1
ATE233104T1 AT98954268T AT98954268T ATE233104T1 AT E233104 T1 ATE233104 T1 AT E233104T1 AT 98954268 T AT98954268 T AT 98954268T AT 98954268 T AT98954268 T AT 98954268T AT E233104 T1 ATE233104 T1 AT E233104T1
Authority
AT
Austria
Prior art keywords
4alkyl
hydrogen
4alkyloxy
halo
optionally substituted
Prior art date
Application number
AT98954268T
Other languages
English (en)
Inventor
Henricus Johannes Mathe Snoeck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE233104T1 publication Critical patent/ATE233104T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT98954268T 1997-09-18 1998-09-10 Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika ATE233104T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202862 1997-09-18
PCT/EP1998/005751 WO1999013871A2 (en) 1997-09-18 1998-09-10 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents

Publications (1)

Publication Number Publication Date
ATE233104T1 true ATE233104T1 (de) 2003-03-15

Family

ID=8228735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954268T ATE233104T1 (de) 1997-09-18 1998-09-10 Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika

Country Status (8)

Country Link
US (1) US6544979B1 (de)
EP (1) EP1011726B1 (de)
JP (1) JP3775780B2 (de)
AT (1) ATE233104T1 (de)
AU (1) AU1146099A (de)
DE (1) DE69811689T2 (de)
WO (1) WO1999013871A2 (de)
ZA (1) ZA988527B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586475B1 (en) * 1998-11-20 2003-07-01 Takeda Chemical Industries, Ltd. β-amyloid protein production/secretion inhibitors
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
PT1401838E (pt) 2001-06-12 2014-06-09 Janssen Pharmaceutica Nv Novos derivados de imidazole tetracíclicos substituidos, processos para a sua preparação, composições farmacêuticas que as compreendem e a sua utilização como um fármaco
DE60231351D1 (de) * 2001-11-23 2009-04-09 Janssen Pharmaceutica Nv Verwendung von Histaminrezeptorantagonisten für die Senkung des intrakranialen Druckes
CA2481855A1 (en) * 2002-04-10 2003-10-23 Ortho-Mcneil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
WO2014087208A2 (en) * 2012-12-06 2014-06-12 Enaltec Labs Pvt. Ltd. A process of preparing alcaftadine
EP3908278A4 (de) * 2019-01-11 2022-09-28 Naegis Pharmaceuticals Inc. Hemmer der leukotriensynthese

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
IL101850A (en) 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
US5629308A (en) * 1992-12-04 1997-05-13 Janssen Pharmaceutica N.V. Imidazo [1,2-A] (pyrrolo, thieno or furano) [2,3-D] azepine derivatives
TW382017B (en) 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
TW527186B (en) * 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators

Also Published As

Publication number Publication date
DE69811689T2 (de) 2003-12-18
EP1011726B1 (de) 2003-02-26
DE69811689D1 (de) 2003-04-03
JP3775780B2 (ja) 2006-05-17
ZA988527B (en) 2000-03-22
EP1011726A2 (de) 2000-06-28
JP2001516716A (ja) 2001-10-02
WO1999013871A2 (en) 1999-03-25
WO1999013871A3 (en) 1999-06-03
US6544979B1 (en) 2003-04-08
AU1146099A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
NO994268L (no) Farnesyltransferase-inhiberende 1,8-annelerte kinolinonderivater substituert med N- eller C-bundede imidazoler
BR0214164A (pt) Ligantes do receptor canabinóide
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
MXPA03010565A (es) Derivados de quinolina como ligandos para receptor del neuropeptido y.
DK1200412T3 (da) Antiproliferative imidazolforbindelser
NO20050073L (no) Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene
MXPA04001400A (es) Derivados de tiazolilo 2,4,5-tri-substituidos y su actividad anti-inflamatoria.
DE69131317D1 (de) HIV-Proteaseinhibitoren
DE69922676D1 (de) N-aralkylaminotetraline als neuropeptid-y-y5-rezeptorliganden
ATE233104T1 (de) Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
ATE410426T1 (de) Heterocyclische verbindungen alsccr5-antagonisten
IT1250749B (it) Composti eterociclici ad attivita' a ii antagonista
TR199900732T2 (xx) PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri.
DE69930648D1 (de) Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole
GEP20084306B (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
MX9804426A (es) Derivados de imidazol fusionados como moduladores de la resistencia a los farmacos multiples.
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
ATE339424T1 (de) 3-substituierte 7-alkylidene-3-cephem-4- carbonsäuren als beta-lactamase inhibitoren
ATE219085T1 (de) 2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren
PT1180094E (pt) Aminoacidos policiclicos fundidos como agentes farmaceuticos
NO20041378L (no) [[2-(Amino-3,4-diokso-1-cyklobuten-1-yl)amino]alkyl]-syrederivater for behandling av smerte
DK0896822T3 (da) 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties